SAN DIEGO, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today announced publication of newly discovered anti-inflammatory steroids naturally present in humans. The paper, "Novel components of the human metabolome: the identification, characterization and anti-inflammatory activity of two 5-androstene tetrols," was published in the journal, "Steroids" [January, Vol.76(1-2)]. Scientists from Harbor BioSciences first identified these tetrols as natural steroids and pre-clinical studies indicate the usefulness of these compounds in treating inflammation-driven diseases including arthritis, type 2 diabetes, and COPD.
